Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conscious Sedation Efficacy of the Novel Medication, MKO Melt (Midazolam, Ketamine, Ondansetron), During Cataract Surgery

NCT03653520 is registered in ClinicalTrials.gov with Avanti Anesthesia as lead sponsor.

NCT NCT03653520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03653520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conscious Sedation Efficacy of the Novel Medication, MKO Melt (Midazolam, Ketamine, Ondansetron), During Cataract Surgery
Lead sponsor
Avanti Anesthesia
Phase
Not applicable
Overall status
Completed
Start date
June 28, 2017
Completion date
November 4, 2017
Enrollment
651 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract